select between over 22,900 AI Tool and 17,900 AI News Posts.
The clinical-stage generative AI drug discovery company recorded a net profit of $35.54 million and an adjusted net profit of $51.23 million, with positive operating cash flow, in its first interim report since listing on the Hong Kong Stock Exchange at the end of 2025. The results, released August 26, 2026, mark the first time an AI-driven drug discovery company of Insilico's profile has reported full-period profitability. The figure worth scrutinizing is not the margin but the revenue mix…
<p>A group of organizations, including nonprofits like LatinoProsperity and labor groups like the California Teamsters, are petitioning California Attorney General Rob Bonta to stop OpenAI from [...]